Funding Opportunity PAR-21-044 from the NIH Guide for Grants and Contracts. The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, and serum) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with tobacco use in the U.S. This opportunity allows investigators to apply for access to the biospecimens from the PATH Study. Information about the PATH Study and this resource may be found on the PATH Study series page at the University of Michigans National Addiction and HIV Data Archive Program (NAHDAP) website, part of the Inter-University Consortium for Political and Social Researchs (ICPSR) website.

Funding Opportunity RFA-AI-20-057 from the NIH Guide for Grants and Contracts. To support research to better define the role of the granuloma, the hallmark structure of pulmonary tuberculosis (TB), in TB disease and disease outcomes. Improved understanding of the granuloma will provide a much-needed knowledge base for the development of improved therapeutic approaches.

Notice NOT-PM-20-002 from the NIH Guide for Grants and Contracts

Notice NOT-OH-20-015 from the NIH Guide for Grants and Contracts

Provide a current CV, cover letter, writing sample (can be a published paper for which applicant is an author/co-author), unofficial transcripts and the names…
From Marquette University - Mon, 28 Sep 2020 22:22:17 GMT - View all Milwaukee, WI jobs

Notice NOT-DK-20-050 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-305 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. For the purpose of this FOA, a group of highly related cancers are those that are derived from the same organ system, such as gastrointestinal, neuroendocrine, head and neck, and other cancers. Other programmatically appropriate groups of cancers may include those centered around a common biological mechanism critical for promoting tumorigenesis and/or cancer progression in organ sites that belong to different organ systems. For example, a SPORE may focus on cancers caused by the same infectious agent or cancers promoted and sustained by dysregulation of a common signaling pathway. In addition, a SPORE may focus on cross-cutting themes such as pediatric cancers or cancer health disparities. The research supported through this program must be translational and must stem from research on human biology using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant.

£32,375 to £40,586: Wellcome Sanger Institute: We’re looking for two postdoctoral fellows in the development of novel single-cell sequencing methods to join the Wellcome Sanger Institute. Hinxton, Saffron Walden, Essex

Notice NOT-MD-21-002 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-055 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-001 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-176 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Scientific Database Curator (Cryo-EM) Location: Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: European COVID-19 Data Platform Project Manager Loca Cambridge, Cambridgeshire, England

Funding Opportunity RFA-MH-20-620 from the NIH Guide for Grants and Contracts. The purpose of the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.

Notice NOT-CA-20-108 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-812 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-002 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-20-701 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Funding Opportunity RFA-HL-21-018 from the NIH Guide for Grants and Contracts. This funding opportunity announcement solicits research project grant (R01) applications that propose to utilize a syndemics (synergistic epidemic) framework to elucidate the role that social, economic, environmental, behavioral, structural, psychological factors play in promoting the synergistic interactions and clustering of heart, lung, blood, and sleep (HLBS) comorbidities and multi-morbidities among people with HIV at the population level. The ultimate goal is to identify strategies that foster integrated and holistic approaches in the clinical management of people living with HIV suffering from HLBS comorbidities and multi-morbidities and to generate useful data to assess the feasibility and cost-effectiveness of such approaches.